HOUSTON, TX – SEPTEMBER 7, 2023 – Procyrion, Inc., a medical device company dedicated to improving outcomes for patients with cardiac and renal impairment, announced today it has successfully secured new inpatient hospital ICD-10-PCS procedure codes applicable to its Aortix™ percutaneous mechanical circulatory support (pMCS) technology. The new codes represent a significant milestone as the company plans to initiate its US IDE pivotal trial, the DRAIN-HF (Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure) study, to evaluate the Aortix system in patients with acute decompensated heart failure (ADHF) in the coming months.
There are three new codes (effective October 1, 2023) allowing facilities to report the implantation, revision, and removal of a short-term external heart pump positioned in the descending thoracic aorta. The implantation/insertion or…